Norman Shealy also pioneered SCS by placing the first system in 1967. According to this theory, the transmission of pain signals depended on a balance of activity from larger A-beta fibers, smaller A-delta, and C fibers which modulated the transmission of pain by an inhibitory interneuron. The gate control theory of pain proposed by Malzack and Wall is the first proposed mechanism of action to explain SCS. Subsequently, percutaneously placed leads by needle placement was pioneered as an alternative means of lead placement without the need for a laminotomy. By the 1980s, with the advent of lithium-based batteries, fully implantable systems were possible, with the implantable pulse generator (IPG) replacing the radiofrequency-based systems. These internal electrodes were connected to a receiving antenna, which interfaced with an external generator and antenna via radiofrequency to generate the power needed for electrical stimulation.
![boston scientific linear dorsal column stimulator boston scientific linear dorsal column stimulator](https://theprocedureguide.com/wp-content/uploads/2020/10/spinal-cord-stimulator-trial-lead-AP-fluoroscopy-1-768x770.jpg)
Early systems consisted of an internal electrode that was surgically implanted via laminectomy. The following five decades would see advancements predominately in the hardware of these devices. The first commercially available SCS system was made by Medtronic in 1968, borrowing from their many developments and advances with cardiac pacemakers. Timeline of advances in spinal cord stimulation. Here we review the historical technologic nuances and recent advances in SCS devices ( Figure 1). Within the past decade, new indications for SCS including management of painful diabetic neuropathy and non-surgical low back pain have increased their utilization in clinical practice. Initially utilized primarily for management of pain conditions including failed back syndrome, refractory angina pectoris, peripheral vascular disease, and complex regional pain syndrome (CRPS), SCS has become a mainstay in chronic pain management. A staple of interventional management of chronic pain has been dorsal column spinal cord stimulation (SCS). With the paradigm shift away from predominantly pharmacologic management, historically reliant upon narcotic management due to concerns from the opioid epidemic, opioid sparing management techniques have become popularized including therapy, non-narcotic pharmacologic management, and interventions. The predominant pain locations in those that responded to this 2019 National Health Interview Survey were back pain, hand/shoulder/arm pain, and hips/knee/foot pain. 2.8) this includes an estimated gross domestic product impact of approximately $296 billion dollars lost in productivity, annually. In the United States alone, it has been found that 50.2 million adults (roughly 20.5% of the US population) report pain daily with significant limitations to social activities and activities of daily living and with associated statistically significant increased days missed from work compared to people without chronic pain (10.3 v.
![boston scientific linear dorsal column stimulator boston scientific linear dorsal column stimulator](https://www.bostonscientific.com/en-EU/products/spinal-cord-stimulator-systems/precision_montage/_jcr_content/maincontent-par/image.img.Montage%20with%20all%20leads%20and%20SP3.jpg)
![boston scientific linear dorsal column stimulator boston scientific linear dorsal column stimulator](https://i2.wp.com/news.bostonscientific.com/image/Precision+SCS2.jpg)
They defined chronic pain as pain that persists or recurs for more than 3 months with further subcategorization into six other subgroups including its own disease entity.
![boston scientific linear dorsal column stimulator boston scientific linear dorsal column stimulator](https://pbortho.com/wp-content/uploads/2020/07/1703_PBOrtho2_0201.jpg)
Chronic pain was systemically classified in the International Classification of Diseases 11 (ICD-11) by the International Association for the Study of Pain (IASP) working group in collaboration with the World Health Organization (WHO) in 2019.